Harbour BioMed and Sinopharm establish innovation R&D consortium
Active Biotech doses first patient in amended tasquinimod myelofibrosis study
Bio-Thera Solutions reports first patient dosed in Phase 1 study of BAT8013
EU approves AstraZeneca's Etcamah combination for 1st-line ER-positive advanced breast cancer
BeOne Medicines expands US manufacturing with USD300m investment
GSK's Jideytro (zidesamtinib) gains US approval for previously treated ROS1-positive NSCLC
Greenwich LifeSciences secures UK approval to expand Phase III breast cancer trial
Elephas Biosciences partners with Invitrocue to promote elive platform in Singapore and Malaysia
Lupin spins out two oncology programmes to Kaveri Therapeutics